With the introduction of new and increasingly effective treatments, it is important for pharmacists to ask, engage and assist people with obesity. But many pharmacists and healthcare professionals don’t feel they have the tools and knowledge for effective management.
Adrian Dix says the drug sold under the brand name Ozempic will become available to more patients in B.C. with Type 2 diabetes, although the expansion falls short of regular benefit coverage.
Lifestyle intervention is recommended as a first-line treatment for diabetes, so researchers sought to fill in the gaps about its effectiveness in older adults.